![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
K Sterling, J Weaver, KL Ho, LC Xu and E Bresnick
Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire 03755-3835.
Rat CYP1A1 promoter activity was suppressed by the presence of a cis negative regulatory element (NRE) at position -843 to -746 in transiently transfected rat H4IIE and human HepG2 hepatoma cells. Removal of the NRE from the promoter-fusion gene constructs caused an increase in the basal promoter activity of 2-6-fold. Co-transfection of the NRE-containing or non-NRE-containing CYP1A1 promoter-fusion gene constructs with a cloned rat NRE, i.e., pNRE, into HepG2 cells caused a 2-fold or greater reduction in constitutive and induced promoter activities. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced expression of the endogenous human CYPA1 was also inhibited by transfection of pNRE into HepG2 cells. Deletion of the sequence from base pairs (bp) -658 to -269 in the NRE-containing construct caused a dramatic decrease of constitutive expression in transiently transfected HepG2 cells, compared with an identical construct that lacked the NRE. Deletion of the sequences between bp -658 and -158 in the CYP1A1 promoter did not affect reporter gene activity, indicating a second site of interaction. At least three different rat liver nuclear proteins bound to the rat NRE, as determined by gel mobility shift and DNase I footprinting assays. A 32-bp sequence within the rat NRE, with significant sequence identity to the 26-bp c-myc, fos/jun-octamer-binding, NRE, was protected from DNAse I cleavage by rat liver nuclear extracts. These data suggested a role for this region in the negative regulation of rat CYP1A1.
This article has been cited by other articles:
|
|
 |
|
  V. Werlinder, M. Backlund, A. Zhukov, and M. Ingelman-Sundberg Transcriptional and Post-Translational Regulation of CYP1A1 by Primaquine J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 206 - 214. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Kurose, M. Tohkin, and M. Fukuhara A Novel Positive Regulatory Element That Enhances Hamster CYP2A8 Gene Expression Mediated by Xenobiotic Responsive Element Mol. Pharmacol., February 1, 1999; 55(2): 279 - 287. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Takahashi, K. Nakayama, S. Itoh, Y. Fujii-Kuriyama, and T. Kamataki Inhibition of the Transcription of CYP1A1 Gene by the Upstream Stimulatory Factor 1 in Rabbits. COMPETITIVE BINDING OF USF1 WITH AhR·Arnt COMPLEX J. Biol. Chem., November 28, 1997; 272(48): 30025 - 30031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Walsh, K. Tullis, R. H. Rice, and M. S. Denison Identification of a Novel Cis-acting Negative Regulatory Element Affecting Expression of the CYP1A1 Gene in Rat Epidermal Cells J. Biol. Chem., September 13, 1996; 271(37): 22746 - 22753. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
